India's Senores Pharma up on buying generic hypertension drug from Wockhardt
** India's Senores Pharma SENO.NS rises 3% to 517.70 rupees ** Drugmaker says it acquired generic version of hypertension drug Enalapril Maleate from Wockhardt WCKH.NS ** Market size for the drug is estimated at $109.2 mln in US, says SENO citing data aggregator Symphony ** Adds, co will fund acquisition for the drug via proceeds it raised during its IPO in December 2024 ** Stock down 7% since its trading debut (Reporting by Kashish Tandon in Bengaluru) ((Kashish.tandon@thomsonreuters.com))
Recent news on Senores Pharmaceuticals
See all newsBrief: Senores Pharmaceuticals Approves Re-Appointment Of Swapnil Jatinbhai Shah As Managing Director
Brief: Senores Pharmaceuticals Says U.S.FDA Completes Inspection At Unit's Vadodara Facility
Brief: Senores Pharmaceuticals Says To Incorporate Units In Mexico, Canada
Brief: Senores Pharmaceuticals Ltd June-Quarter Consol Net Profit 307.2 Million Rupees
Brief: Senores Pharmaceuticals March-Quarter Consol Net Profit 316.1 Million Rupees